Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALIGN TECHNOLOGY INCALGN · Entity 3488 | Director | May 20, 2026 | May 22, 2026 |
| REVA Medical, Inc.RVA.AX · Entity 11998 | Director | June 29, 2018 | July 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALIGN TECHNOLOGY INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,454 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 2,326 · Balance 27,454 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 2,326 · Balance 0 F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,448 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 2,448 · Balance 2,448 F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person.
F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date.
REVA Medical, Inc.
Report date June 29, 2018 · Filed July 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 371,380.5 |
Reported balance
After 2018-06-29 transaction · row 1
1 source rowRow 1 · 2018-06-29 · Purchase · Acquired 19,631.5 · Balance 371,380.5 F1: Represents the purchase of 196,315 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange. F2: The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the purchase of 196,315 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange.
F2: The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date May 31, 2024 · Filed May 31, 2024
Section 16 reporting ended · disclosed 2024-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Disposition to issuer · Disposed 5,281 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.59 · Expires 2029-02-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-31 · Disposition to issuer · Disposed 28,688 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"),
F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F3: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 23:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237329 · ownership.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,448 Underlying: Common Stock · 2,448 shares Expires not disclosed F2 · derivative.exercise_price: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.exercise_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.expiration_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237329 · ownership.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F1 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F1 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237329 · ownership.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:10 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 2,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014202 · form4-05222025_090535.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,326 Underlying: Common Stock · 2,326 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F3 · derivative.expiration_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:10 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014202 · form4-05222025_090535.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. F2 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:10 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014202 · form4-05222025_090535.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2024 Filed Aug 19, 2024 22:35 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021632 · form4-08192024_100859.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,597 F2 · kind: The reporting person donated these shares to a donor-advised fund which will use the gifted shares for charitable purposes. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 22:35 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | PurchaseCommon Stock | 6,500 | $235.33 | $1,529,645.00 |
DisclosureSEC source: 0001415889-24-021632 · form4-08192024_100859.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,247 F1 · kind: The reporting person redeemed shares of the Issuer's common stock from an exchange fund in exchange for the cancellation of shares of the exchange fund. The issuer's common stock was valued at $235.33 per share for purposes of determining the number of shares of common stock to be redeemed. F1 · price: The reporting person redeemed shares of the Issuer's common stock from an exchange fund in exchange for the cancellation of shares of the exchange fund. The issuer's common stock was valued at $235.33 per share for purposes of determining the number of shares of common stock to be redeemed. Read SEC document |
| May 31, 2024 Filed May 31, 2024 20:29 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Disposition to issuerStock Option · Derivative | 28,688 | Not disclosed Strike: $6.59 | Not disclosed |
DisclosureSEC source: 0001642545-24-000114 · wk-form4_1717187335.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,688 shares Expires 2029-02-01 F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. Read SEC document |
| May 31, 2024 Filed May 31, 2024 20:29 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Disposition to issuerCommon Stock | 5,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001642545-24-000114 · wk-form4_1717187335.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2 · price: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:13 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014465 · form4-05242024_080522.xml · derivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531 Underlying: Common Stock · 1,531 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.expiration_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:01 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014015 · form4-05212024_110502.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. F2 · derivative.expiration_date: 100% of the restricted stock units granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:01 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014015 · form4-05212024_110502.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 22:49 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-037555 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,281 Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:24 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031132 · doc4.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,372 Underlying: Common Stock · 1,372 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:24 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,486 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031132 · doc4.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,486 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:24 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031132 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 23:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 994 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039540 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,545 Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:01 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,486 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030683 · doc4.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,486 Underlying: Common Stock · 1,486 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:01 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 699 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030683 · doc4.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 699 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person. Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:01 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030683 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2022 Filed May 13, 2022 21:33 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | PurchaseCommon Stock | 1,000 | $264.42 | $264,420.00 |
DisclosureSEC source: 0001209191-22-028926 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,190 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:58 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 1,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-063688 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,190 Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:28 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,500 | $675.00 | $1,687,500.00 |
DisclosureSEC source: 0001209191-21-049065 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,667 F1 · kind: All sales in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 21:03 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,500 | $650.00 | $1,625,000.00 |
DisclosureSEC source: 0001209191-21-046680 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,167 F1 · kind: All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 22:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,500 | $625.00 | $1,562,500.00 |
DisclosureSEC source: 0001209191-21-043756 · doc4.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,710 F1 · kind: All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 22:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,500 | $618.45 | $1,546,125.00 |
DisclosureSEC source: 0001209191-21-043756 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,210 F1 · kind: All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person Read SEC document |
| June 28, 2021 Filed Jul 10, 2021 01:43 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-010319 · dp154200_4-larkin.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,551 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest on 6/25/2022, subject to the Reporting Person's continued service through such date. Read SEC document |
| May 21, 2021 Filed Jun 29, 2021 22:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043756 · doc4.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,667 Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:03 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 699 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035049 · doc4.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699 Underlying: Common Stock · 699 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:03 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,694 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035049 · doc4.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:03 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035049 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 36 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031392 · doc4.xml · nonDerivative · entry 5 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,016 Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 1,102 | $600.12 | $661,332.35 |
DisclosureSEC source: 0001209191-21-031392 · doc4.xml · nonDerivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F4 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $600.04 to $600.23, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 418 | $599.31 | $250,511.87 |
DisclosureSEC source: 0001209191-21-031392 · doc4.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,154 F3 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $599.00 to $599.37, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 2,415 | $598.51 | $1,445,395.37 |
DisclosureSEC source: 0001209191-21-031392 · doc4.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,572 F2 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $598.00 to $598.96, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 1,065 | $597.44 | $636,271.58 |
DisclosureSEC source: 0001209191-21-031392 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,987 F1 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $596.91 to $597.92, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2020 Filed Jan 12, 2021 02:49 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003171 · doc5.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,052 Read SEC document |
| October 30, 2020 Filed Nov 4, 2020 23:56 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056999 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,131 Read SEC document |
| July 17, 2020 Filed Jul 22, 2020 00:33 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 2,701 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-014010 · dp132633_4-larkin.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,701 Read SEC document |
| July 09, 2020 Filed Jan 12, 2021 02:49 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 37 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003171 · doc5.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,094 Read SEC document |
| May 20, 2020 Filed May 21, 2020 22:15 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,694 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031423 · doc4.xml · derivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,694 Underlying: Common Stock · 1,694 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:13 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030658 · doc4.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:13 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantCommon Stock | 1,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030658 · doc4.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,293 Read SEC document |
| March 06, 2020 Filed May 19, 2020 22:13 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 135 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030658 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,065 Read SEC document |
| December 16, 2019 Filed Jan 22, 2020 00:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001593575-20-000003 · primary_doc.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Read SEC document |
| November 20, 2019 Filed Jan 22, 2020 00:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0001593575-20-000003 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,463 Read SEC document |
| October 02, 2019 Filed Jan 22, 2020 00:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001593575-20-000003 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,501 Read SEC document |
| May 30, 2019 Filed May 31, 2019 22:44 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 9,734 | $296.65 | $2,887,555.08 |
DisclosureSEC source: 0001234778-19-000004 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,257 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.8175 to $297.11, inclusive. The reporting person undertakes to provide Align Technology Inc., any security holder of Align Technology Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 30, 2019 Filed Jul 16, 2019 00:06 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 18,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001234778-19-000005 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,557 F1 · price: The Reporting Person contributed 18,700 shares to an exchange fund on May 30, 2019 in connection with the Reporting Person's execution of an irrevocable subscription to such exchange fund. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.